🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a study looking at advanced imaging such as PET/CT and MRI to see i...
Status
Completed
Location
Central New York PET Center
Start Date
2002-01
Trial ID
NCT00639535
Alzheimer's disease (AD) is usually associated with aging, age being the pr...
Status
Unknown
Location
Assistance Publique - Hôpitaux de Marseille
Start Date
2009-10
Trial ID
NCT00987090
\[18 F\]fluorodeoxyglucose (18F-FDG) positron emission tomography-magnetic ...
Status
Recruiting
Location
Institut de cancérologie Strasbourg Europe
Start Date
2023-10-12
Trial ID
NCT06083103
Treatments Being Tested
In this longitudinal study, the investigators will follow Parkinson's disea...
Status
Active Not Recruiting
Location
Feinstein Institutes for Medical Research
Start Date
2020-02-24
Trial ID
NCT04228172
Treatments Being Tested
This phase II trial tests the accuracy of functional imaging (FFNP)-positro...
Status
Recruiting
Location
Siteman Cancer Center at Washington University
Start Date
2024-07-22
Trial ID
NCT06179303
Treatments Being Tested
This pilot clinical trial studies gene expression analysis and fludeoxygluc...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2014-06
Trial ID
NCT02112162
This phase II trial studies how well fludeoxyglucose F 18 (FDG)-labeled pos...
Status
Completed
Location
Harborview Medical Center
Start Date
2007-10
Trial ID
NCT00564733
Rationale: improving the early detection of AD at prodromal pre-dementia st...
Status
Completed
Location
university hospital of CAEN
Start Date
2009-04
Trial ID
NCT01325259
Treatments Being Tested
RATIONALE: New imaging procedures, such as fluorine F 18 fluorodopa-labeled...
Status
Completed
Location
Mayo Clinic
Start Date
2010-07-26
Trial ID
NCT01165632
This phase II trial is studying how well giving irinotecan together with ci...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2003-06
Trial ID
NCT00062374